Sign inJoin waitlistJoin the waitlist

David Hudesman

Center Director | Inflammatory Bowel · NYU Grossman School of Medicine

Credentials: · · ·

History

NYU Grossman School of Medicine
Present
Inflammatory Bowel Disease Center · NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Beth Israel Medical Center-North Division
2008–2011
Internal Medicine
Icahn School of Medicine at Mount Sinai
2005–2008
Rutgers University
2001–2005

Research

Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Cell · 2020 · 361 citations
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium
The American Journal of Gastroenterology · 2016 · 273 citations
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
The American Journal of Gastroenterology · 2018 · 153 citations

Shannon Chang
31 papers · 1 as a fellow
Jordan Axelrad
25 papers · 1 as a fellow
Corey Siegel
15 papers
Dana Lukin
15 papers
Parambir Dulai
15 papers
Simon Hong
15 papers · 6 as a fellow
AS
Arun Swaminath
13 papers
Bruce Sands
13 papers
Jean-Frederic Colombel
13 papers
Lisa Malter
13 papers
SK
Sunanda Kane
13 papers
Edward Loftus
12 papers

Clinical trials

Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis
Principal investigator · Not yet recruiting
NYU Langone Health
2026–2029
Induction Optimization With Stelara for Crohn's Disease
Principal investigator · Terminated · Phase 4
NYU Langone Health
2022–2024
Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples
Principal investigator · Completed
NYU Langone Health
2018–2022
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Site PI · Recruiting
University of North Carolina, Chapel Hill
2025–2028